The research on subtherapeutic doses is limited, and long-term effects remain unknown
General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide
Dempsey, in collaboration with the Nature Immunology team
As of 2026, licensed pharmacies cannot legally compound them for human use
All State and Union Territory drug controllers have also been asked to actively monitor print, electronic, digital, social-media, and outdoor platforms for non-compliant advertisements or surrogate promotional activities relating to these drugs
Chem Soc Rev 51:464484 Hao F, Yan ZY, Yan XP (2022) Recent advances in research on the effect of physicochemical properties on the cytotoxicity of metalorganic frameworks